Palvella Therapeutics
PVLA
18 hedge funds and large institutions have $40.5M invested in Palvella Therapeutics in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
38% more funds holding
Funds holding: 13 → 18 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.99% less ownership
Funds ownership: 46.48% → 44.49% (-2%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
65% less capital inflows, than outflows
Capital inflows: $746K | Capital outflows: $2.15M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$334K |
| 2 |
Lombard Odier Asset Management (USA)
New York
|
+$239K |
| 3 |
Spark Investment Management
New York
|
+$63.5K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$31.6K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$26.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$1.74M |
| 2 |
Sphera Funds Management
Tel Aviv,
Israel
|
-$189K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$158K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$44K |
| 5 |
Virtu KCG Holdings
New York
|
-$21.5K |
PVLA Hedge Fund Activity: Q4 2015 in Review
18 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Palvella Therapeutics (PVLA) for Q4 2015, worth a combined $40.5M — up 20% from $33.8M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new PVLA positions and 1 closed out — a net gain of 5 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $334K. The largest seller was Emerald Mutual Fund Advisers Trust, exiting entirely with an estimated $1.74M sold.
- 18 institutional investors held Palvella Therapeutics (PVLA) as of Q4 2015, up from 13 in Q3 2015.
- Funds reported $40.5M of Palvella Therapeutics stock for Q4 2015, up 20% quarter-over-quarter.
- 6 funds opened new Palvella Therapeutics positions in Q4 2015 and 1 closed out, a net change of +5 holders.
- The largest Palvella Therapeutics buyer in Q4 2015 was Millennium Management, an estimated $334K added.
- The largest Palvella Therapeutics seller in Q4 2015 was Emerald Mutual Fund Advisers Trust, an estimated $1.74M sold.
Based on aggregated 13F filings for Q4 2015.